Brief: Iveric Bio - Expects Top-Line Data From Gather2 To Become Available During H2 Of 2022
12/07/2021 22:02
July 12 (Reuters) - Iveric Bio Inc ISEE.O :
* IVERIC BIO - EXPECTS TOP-LINE DATA FROM GATHER2 TO BECOME
AVAILABLE DURING H2 OF 2022
* IVERIC BIO - SUBJECT TO REGULATORY REVIEW, CO PLANS TO
INITIATE
PHASE 1/2 CLINICAL TRIAL OF IC-200 DURING Q4 OF 2021
Source text: https://bit.ly/3ySf2Nk
Further company coverage: ISEE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on IVERIC bio
See all newsBrief: Astellas Pharma Inc - Astellas Completes Acquisition Of Iveric Bio
Analysis: Amgen's antitrust woes spur wider pharmaceutical deal fears
Iveric Bio Inc Reports Results For The Quarter Ended In March: Earnings Summary
The end of cheap credit could hurry Japanese M&A
U.S. STOCKS ON THE MOVE-US banks, Biomea Fusion, Tutor Perini